Early Phase 1 Risk Clinical Trials
3 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–3 of 3 trials
Recruiting
Early Phase 1
A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer
High-risk Prostate Cancer
Edwin Posadas, MD20 enrolled1 locationNCT06888102
Not Yet Recruiting
Early Phase 1
SUBDUE-3: A Phase 0 study of SUB-urothelial DUrvalumab-Zirconium to investigate local and systemic distribution of Durvalumab when injected in the sub-urothelium in adult subjects with muscle invasive bladder cancer or high-risk non-muscle invasive bladder tumours.
Muscle invasive or high risk non muscle invasive bladder cancer
South Metropolitan Health Service, Fiona Stanley Hospital, 11 Robin Warren Drive, MURDOCH WA 61503 enrolled1 locationACTRN12624001245583
Recruiting
Early Phase 1
Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma
High Risk of Recurrence
Chang Gung Memorial Hospital40 enrolled1 locationNCT06327269